Evecxia Therapeutics Competitors and Similar CompaniesClear all
Alector's competitors and similar companies include ACADIA Pharmaceuticals and Suven Life Sciences.
 Alector Alector is a biotechnology company that develops therapies for the treatment of neurodegenerative diseases. |  ACADIA Pharmaceuticals ACADIA Pharmaceuticals (formerly Receptor Technologies) is a biopharmaceutical company developing medicines that address medical needs in related central nervous system (CNS) disorders. |  Suven Life Sciences Suven Life Sciences is a biopharmaceutical company specialized in NCE-based CRAMS. | |
Founding Date | Founding Date 2013 | Founding Date 1993 | Founding Date 1989 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations San Francisco, US HQ | Locations San Diego, US HQ Princeton, US | Locations Hyderabad, IN HQ Dasaigudem, IN Hyderabad, IN Sangareddy, IN South Brunswick Township, US |
Employees | Employees 2382% decrease | Employees 513 | Employees 141 |
Valuation ($) | Valuation ($) 495.3 m | Valuation ($) 2.4 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $21m (FY, 2025) | Revenue (est.) $1.1b (FY, 2025) | Revenue (est.) ₹71.1m (FY, 2026) |
Cost of goods | Cost of goods N/A | Cost of goods $89m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $982.5m (FY, 2025) | Gross profit ₹210.4m (FY, 2026) |
Net income | Net income ($142.9m) (FY, 2025) | Net income $391m (FY, 2025) | Net income (₹2.8b) (FY, 2026) |
Funding | |||
Total funding raised | Total funding raised $ 194.5m | Total funding raised $ 770.8m | Total funding raised $ 32m |
For sources of this data, please see the company profile
View Company Profiles
ACADIA Pharmaceuticals
HQ
San Diego, US
Employees
513
ACADIA Pharmaceuticals (formerly Receptor Technologies) is a biopharmaceutical company developing medicines that address medical needs in related central nervous system (CNS) disorders.
View companySuven Life Sciences
HQ
Hyderabad, IN
Employees
141
Suven Life Sciences is a biopharmaceutical company specialized in NCE-based CRAMS.
View company